CLEC9A and neoplasm: CLEC9A (also called DNGR-1) allows dendritic cells to engulf necrotic cells and then cross-present tumor-derived antigens on MHC I through a mechanism which ruptures the efferosome, thus allowing necrotic-cell antigens to be loaded onto MHC I in the endoplasmic reticulum [249,250].